VTRS
NASDAQStockViatris Inc.
$13.85-0.13 (-0.89%)
52-Week Range
$7.26
$16.13
Key Stats
Market Cap
15.9B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.80
Volume
8.3M
Avg Volume
12.4M
Performance
1M
-13.48%
3M
+18.45%
6M
+43.75%
YTD
+10.75%
1Y
+49.35%
3Y
+40.39%
5Y
-5.93%
Price Chart
ETF Exposure
VTRS is held by 230 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IHE | iShares U.S. Pharmaceuticals ETF | 4.23% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.92% |
| DWLD | Davis Select Worldwide ETF | 2.60% |
| PJP | Invesco Pharmaceuticals ETF | 2.55% |
| RDIV | Invesco S&P Ultra Dividend Revenue ETF | 2.42% |
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 2.36% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 2.05% |
| RYH | Invesco S&P 500 Equal Weight Health Care ETF | 2.05% |
| DUSA | Davis Select U.S. Equity ETF | 1.99% |
| RNDV | First Trust US Equity Dividend Select ETF | 1.49% |
| EZM | WisdomTree U.S. MidCap Fund | 1.36% |
| WTV | WisdomTree U.S. Value Fund | 1.33% |
| SPYD | State Street SPDR Portfolio S&P 500 High Dividend ETF | 1.31% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 1.23% |
| DON | WisdomTree U.S. MidCap Dividend Fund | 1.21% |
| SYLD | Cambria Shareholder Yield ETF | 1.15% |
| FCFY | First Trust S&P 500 Diversified Free Cash Flow ETF | 1.08% |
| TEQI | T. Rowe Price Equity Income ETF | 1.08% |
| RPV | Invesco S&P 500 Pure Value ETF | 1.06% |
| MRND | IQ U.S. Mid Cap R&D Leaders ETF | 0.94% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.84% |
| PPH | VanEck Pharmaceutical ETF | 0.82% |
| DFAT | Dimensional - US Targeted Value ETF | 0.73% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.71% |
| SIFI | Harbor Ares Systematic Multi-Sector Income ETF (SIFI) | 0.65% |
| TVAL | T. Rowe Price Value ETF | 0.64% |
| GPAL | Goldman Sachs ActiveBeta Paris-Aligned U.S. Large Cap Equity ETF | 0.62% |
| FLQM | Franklin U.S. Mid Cap Multifactor Index ETF | 0.59% |
| FMDE | FIDELITY ENHANCED MID CAP ETF | 0.59% |
| AUSF | Global X - Adaptive U.S. Factor ETF | 0.59% |
| AVMV | Avantis U.S. Mid Cap Value ETF | 0.59% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.58% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.58% |
| ONEY | State Street SPDR Russell 1000 Yield Focus ETF | 0.54% |
| USVM | VictoryShares US Small Mid Cap Value Momentum ETF | 0.51% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.48% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.46% |
| FELV | FIDELITY ENHANCED LARGE CAP VALUE ETF | 0.44% |
| HEJD | VictoryShares Hedged Equity Income ETF | 0.43% |
| MXDU | Nationwide Maximum Diversification U.S. Core Equity ETF | 0.43% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.43% |
| STXM | Strive Mid-Cap ETF | 0.42% |
| DHS | WisdomTree U.S. High Dividend Fund | 0.41% |
| JPME | JPMorgan Diversified Return U.S. Mid Cap Equity ETF | 0.39% |
| DFSV | Dimensional - US Small Cap Value ETF | 0.39% |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 0.36% |
| BSCU | Invesco BulletShares 2030 Corporate Bond ETF | 0.35% |
| VBR | Vanguard Small-Cap Value ETF | 0.35% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 0.35% |
| AVLV | Avantis U.S. Large Cap Value ETF | 0.34% |
Page 1 of 5Next
About VTRS ETF Exposure
Viatris Inc. (VTRS) is held by 230 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 15.9B, VTRS is a widely held institutional stock. The stock currently trades at $13.85. Investors can gain exposure to VTRS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VTRS, sorted by portfolio weight.